NEOLEUKIN THERAPEUTICS INC - COM (NLTX) Institutional Ownership

CUSIP: 64049K104

13F Institutional Holders and Ownership History from Q3 2019 to Q3 2023

Type / Class
Equity / COM
Symbol
NLTX
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 64049K104?
CUSIP 64049K104 identifies NLTX - NEOLEUKIN THERAPEUTICS INC - COM in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Institutional Holders of NEOLEUKIN THERAPEUTICS INC - COM (NLTX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2023 Q3 0 $0 -$14,343,165 0
2023 Q2 17,283,838 $14,343,165 +$1,877,909 $0.83 34
2023 Q1 15,050,814 $10,534,008 -$1,345,378 $0.70 35
2022 Q4 17,021,582 $8,661,824 -$880,458 $0.51 44
2022 Q3 18,711,231 $11,975,000 -$2,153,724 $0.64 44
2022 Q2 20,796,660 $21,420,000 -$4,503,223 $1.03 53
2022 Q1 24,577,317 $46,280,000 -$3,973,496 $1.88 78
2021 Q4 24,652,991 $118,815,000 -$11,055,315 $4.82 77
2021 Q3 25,853,321 $187,061,277 -$12,636,694 $7.23 81
2021 Q2 26,949,913 $248,757,853 -$10,529,379 $9.23 81
2021 Q1 27,774,384 $341,892,475 +$216,334 $12.31 80
2020 Q4 27,715,729 $390,791,407 +$4,193,267 $14.10 83
2020 Q3 27,551,096 $330,613,844 +$25,483,909 $12.00 80
2020 Q2 25,131,800 $417,161,785 +$48,829,284 $16.60 72
2020 Q1 22,749,558 $258,733,000 +$35,271,764 $11.38 60
2019 Q4 19,582,683 $241,249,000 +$1,098,877 $12.32 54
2019 Q3 18,839,836 $53,691,000 +$53,691,000 $2.85 35